|フェンテルミンは[[substituted amphetamine/ja|置換アンフェタミン]]であり、トピラマートは作用機序が不明である。
|[[Substituted amphetamine/ja]]
...
22 KB (659 words) - 09:48, 8 March 2024
* [[Substituted amphetamine#Partial list of substituted amphetamines|List of substituted amphetamines]]
...
4 KB (491 words) - 12:41, 6 January 2023
|Phentermine is a [[substituted amphetamine]] and topiramate has an unknown mechanism of action
|[[Substituted amphetamine]]
...
17 KB (2,406 words) - 18:16, 7 March 2024
|Phentermine is a [[substituted amphetamine]] and topiramate has an unknown mechanism of action
|[[Substituted amphetamine]]
...
18 KB (2,460 words) - 18:15, 7 March 2024
* [[Racemic amphetamine/ja|ラセミアンフェタミン]]、[[phendimetrazine/ja|フェンディメトラジン]]、[[diethylpropion/ja|ジエチルプ
...
27 KB (487 words) - 13:24, 5 March 2024
# [[Stimulant|覚醒剤]]: [[methylphenidate/ja|メチルフェニデート]], [[amphetamine/ja|アンフェタミン]]
...s disease/ja|パーキンソン病]]など）治療薬、[[nootropics/ja|向精神薬]]、[[stimulant/ja|興奮薬]]（[[amphetamine/ja|アンフェタミン]]を含む）、[[benzodiazepine/ja|ベンゾジアゼピン系薬剤]]、[[cyclopyrroloneslcyclop
...
58 KB (1,845 words) - 17:09, 5 November 2023
====Epinephrine, norepinephrine, and amphetamine====
...nasal decongestant under the trade name [[Benzedrine|Benzedrine Inhaler.]] Amphetamine was eventually developed for the treatment of [[narcolepsy]], [[post-enceph
...
60 KB (8,551 words) - 22:13, 8 January 2023
...Stimulant|Stimulant]]s: [[methylphenidate|methylphenidate]], [[amphetamine|amphetamine]]
...nootropics|nootropics]], [[stimulant|stimulant]]s (including [[amphetamine|amphetamine]]s), [[benzodiazepine|benzodiazepine]]s, [[cyclopyrrolones|cyclopyrrolones]
...
52 KB (6,923 words) - 17:09, 5 November 2023
...Stimulant|Stimulant]]s: [[methylphenidate|methylphenidate]], [[amphetamine|amphetamine]]
...nootropics|nootropics]], [[stimulant|stimulant]]s (including [[amphetamine|amphetamine]]s), [[benzodiazepine|benzodiazepine]]s, [[cyclopyrrolones|cyclopyrrolones]
...
54 KB (7,245 words) - 17:08, 5 November 2023
...doi = 10.1016/j.toxlet.2011.10.010 | name-list-style = vanc }}</ref> and [[amphetamine]] derivatives such as [[para-Methoxy-N-methylamphetamine|PMMA]].<ref>{{cite
...
22 KB (2,885 words) - 17:22, 3 January 2023
* [[Racemic amphetamine]], [[phendimetrazine]], [[diethylpropion]], and [[phentermine]] are approve
...
22 KB (3,284 words) - 15:45, 4 March 2024
* [[Racemic amphetamine]], [[phendimetrazine]], [[diethylpropion]], and [[phentermine]] are approve
...
23 KB (3,374 words) - 15:44, 4 March 2024
...ethcathinone]] or any active/scheduled analogs of [[Phenylethylamines]]/ [[amphetamine]]."{{Citation needed|date = February 2016|reason = can't verify this wordin
...
26 KB (3,677 words) - 16:28, 3 January 2023
* [[Amphetamine]]
...
27 KB (3,602 words) - 17:17, 3 January 2023
...力を持つ。第二のグループは[[pro-opiomelanocortin/ja|プロオピオメラノコルチン]]（POMC）と[[cocaine- and amphetamine-regulated transcript/ja|コカイン・アンフェタミン制御転写物]]（CART）を共発現し、VMHへの刺激入力とLHへの抑制入力を持
...
82 KB (2,433 words) - 14:15, 7 March 2024
...胞外亜鉛[[binding site/ja|結合部位]]が存在し、亜鉛が結合するとドーパミンの[[reuptake/ja|再取り込み]]を阻害し、[[amphetamine/ja|アンフェタミン]]による[[neurotransmitter efflux/ja|ドーパミンの流出]]を増幅する''[[in vitro|試験管
...
84 KB (3,193 words) - 21:48, 20 April 2024
...econd group coexpresses [[pro-opiomelanocortin]] (POMC) and [[cocaine- and amphetamine-regulated transcript]] (CART) and has stimulatory inputs to the VMH and inh
...
69 KB (10,124 words) - 14:18, 5 March 2024
...econd group coexpresses [[pro-opiomelanocortin]] (POMC) and [[cocaine- and amphetamine-regulated transcript]] (CART) and has stimulatory inputs to the VMH and inh
...
71 KB (10,348 words) - 14:18, 5 March 2024
...] which, upon zinc binding, inhibits dopamine [[reuptake]] and amplifies [[amphetamine]]-induced [[neurotransmitter efflux|dopamine efflux]] ''[[in vitro]]''. The
...
68 KB (10,208 words) - 16:30, 20 April 2024
...] which, upon zinc binding, inhibits dopamine [[reuptake]] and amplifies [[amphetamine]]-induced [[neurotransmitter efflux|dopamine efflux]] ''[[in vitro]]''. The
...
69 KB (10,504 words) - 16:29, 20 April 2024